Trial · NCT07546370
The Effectiveness of Topical Prilocaine-Lidocaine Cream Plus Acetaminophen and Naproxen Compared to Lidocaine Injection Plus Acetaminophen and Naproxen to Manage Pain During IntraUterine Device Insertion
NCT07546370, Phase 4, Not yet recruiting, Monakshi Sawhney
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. The Effectiveness of Topical Prilocaine-Lidocaine Cream Plus Acetaminophen and Naproxen Compared to Lidocaine Injection Plus Acetaminophen and Naproxen to Manage Pain During IntraUterine Device Insertion. Trials, record NCT07546370. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07546370
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
The Effectiveness of Topical Prilocaine-Lidocaine Cream Plus Acetaminophen and Naproxen Compared to Lidocaine Injection Plus Acetaminophen and Naproxen to Manage Pain During IntraUterine Device Insertion
- NCT number
- NCT07546370
- Status
- Not yet recruiting
- Phases
- Phase 4
- Enrollment
- 66 participants, estimated
- Lead sponsor
- Monakshi Sawhney
- Conditions
- Pain During Intrauterine Device Insertion
- Interventions
- Prilocaine, Lidocaine, Lidocaine HCl 1%
- First posted
- 2026-04-22
- Last updated
- 2026-04-22
Source ClinicalTrials.gov
Registered outcomes7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Numerical Rating Scale | Baseline to end of treatment on day 1 | Zero is equivalent to no pain and 10 indicates the worst possible pain |
| Secondary | State Trait Anxiety Inventory | Baseline | Participants will answer a questionnaire on their level of anxiety. |
| Secondary | McGill Pain Questionnaire | end of treatment on day 1 | Participants will describe the pain/ if any they experienced during the procedure |
| Secondary | Ease of Insertion | end of treatment on day 1 | Clinicians inserting the intrauterine device will rate on a numerical scale the difficulty of inserting the device, zero being extremely easy and ten being extremely difficult. |
| Secondary | Non Pharmacological Measures | end of treatment on day 1 | Participants will answer a questionnaire on the type of nonpharmacological measures they used during the procedure |
| Secondary | Adverse Reactions | at day 2 | Participants will answer a questionnaire about any adverse reactions they may have experienced. |
| Other | Demographic Information | baseline | Participants will answer a questionnaire about their current and past health. In addition, to sociodemographic information ( such as age, sex, gender) |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers14
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07546370
GET https://conductscience.org/api/trials/v1/NCT07546370/registered